141 related articles for article (PubMed ID: 35605900)
1. Implementing virtual crossmatch based diagnostic management teams in human leukocyte antigen laboratories and transplant programs.
Wade J; Roback JD; Krummey SM; Gebel HM; Bray RA; Sullivan HC
Transpl Immunol; 2022 Aug; 73():101629. PubMed ID: 35605900
[TBL] [Abstract][Full Text] [Related]
2. Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons.
Puttarajappa CM; Tevar AD; Hoffman W; Degenholtz H; Schinstock CA; Gunabushanam V; Zeevi A; Xu Q; Hariharan S
Hum Immunol; 2023 Mar; 84(3):214-223. PubMed ID: 36581507
[TBL] [Abstract][Full Text] [Related]
3. HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.
Kamoun M; Phelan D; Noreen H; Marcus N; Klingman L; Gebel HM
Hum Immunol; 2017 Jan; 78(1):19-23. PubMed ID: 27840088
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of virtual crossmatch (VXM) prediction of physical crossmatch (PXM) results of donor specific antibody (DSA) in routine pretransplant settings-a single-center experience.
Olszowska-Zaremba N; Zagożdżon R; Gozdowska J
Transpl Immunol; 2022 Jun; 72():101583. PubMed ID: 35314352
[TBL] [Abstract][Full Text] [Related]
5. Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.
Locke AF; Hickey M; Valenzuela NM; Butler C; Sosa R; Zheng Y; Gjertson D; Reed EF; Zhang Q
Transplantation; 2023 Aug; 107(8):1776-1785. PubMed ID: 36944607
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Rapid Optimized 96-well Tray Flow Cytometric Crossmatch (Halifax-FCXM) with Luminex Single Antigen Test.
Yoo J; Lee S; Lee HW; Lee S; Choi J; Han J; Kang H; Choi A; Hee Jang J; Oh EJ
Hum Immunol; 2021 Apr; 82(4):302-308. PubMed ID: 33744026
[TBL] [Abstract][Full Text] [Related]
7. Development of data-driven models for the flow cytometric crossmatch.
Weimer ET; Newhall KA
Hum Immunol; 2019 Dec; 80(12):983-989. PubMed ID: 31530432
[TBL] [Abstract][Full Text] [Related]
8. Out with the old, in with the new: Virtual versus physical crossmatching in the modern era.
Morris AB; Sullivan HC; Krummey SM; Gebel HM; Bray RA
HLA; 2019 Dec; 94(6):471-481. PubMed ID: 31515937
[TBL] [Abstract][Full Text] [Related]
9. Utilizing proficiency testing survey data to create advanced educational content: the virtual crossmatch challenge model.
Hod-Dvorai R; Philogene MC; Timofeeva O; Gimferrer I; Dunckley H; Greenshields A; Jindra P
Front Genet; 2023; 14():1256498. PubMed ID: 37811147
[TBL] [Abstract][Full Text] [Related]
10. The omission of the "wet" pre-transplant crossmatch in renal transplant centres in Scotland.
Turner D; Battle R; Akbarzad-Yousefi A; Little AM
HLA; 2019 Jul; 94(1):3-10. PubMed ID: 31025501
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Physical Crossmatch and Virtual Crossmatch to Identify Preexisting Donor-Specific Human Leukocyte Antigen (HLA) Antibodies and Outcome Following Kidney Transplantation.
Peng B; Zhuang Q; Yu M; Li J; Liu Y; Zhu L; Ming Y
Med Sci Monit; 2019 Feb; 25():952-961. PubMed ID: 30712055
[TBL] [Abstract][Full Text] [Related]
12. Virtual HLA Crossmatching as a Means to Safely Expedite Transplantation of Imported Pancreata.
Eby BC; Redfield RR; Ellis TM; Leverson GE; Schenian AR; Odorico JS
Transplantation; 2016 May; 100(5):1103-10. PubMed ID: 26950720
[TBL] [Abstract][Full Text] [Related]
13. (F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch.
Sullivan HC; Dean CL; Liwski RS; Biswas S; Goodman AL; Krummey S; Gebel HM; Bray RA
Hum Immunol; 2018 Oct; 79(10):711-715. PubMed ID: 30081064
[TBL] [Abstract][Full Text] [Related]
14. A blueprint for electronic utilization of ambiguous molecular HLA typing data in organ allocation systems and virtual crossmatch.
Kaur N; Pinelli D; Kransdorf EP; Pando MJ; Smith G; Murphey CL; Kamoun M; Bray RA; Tambur A; Gragert L
Hum Immunol; 2020; 81(2-3):65-72. PubMed ID: 32057520
[TBL] [Abstract][Full Text] [Related]
15. Principles of Virtual Crossmatch Testing for Kidney Transplantation.
Bhaskaran MC; Heidt S; Muthukumar T
Kidney Int Rep; 2022 Jun; 7(6):1179-1188. PubMed ID: 35685330
[TBL] [Abstract][Full Text] [Related]
16. The evolution and clinical impact of human leukocyte antigen technology.
Gebel HM; Bray RA
Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):598-602. PubMed ID: 20720491
[TBL] [Abstract][Full Text] [Related]
17. A Virtual Crossmatch-based Strategy Facilitates Sharing of Deceased Donor Kidneys for Highly Sensitized Recipients.
Roll GR; Webber AB; Gae DH; Laszik Z; Tavakol M; Mayen L; Cunniffe K; Syed S; Hirose R; Freise C; Feng S; Roberts JP; Ascher NL; Stock PG; Rajalingam R
Transplantation; 2020 Jun; 104(6):1239-1245. PubMed ID: 31449187
[TBL] [Abstract][Full Text] [Related]
18. The shared epitope phenomenon-A potential impediment to virtual crossmatch accuracy.
Garcia-Sanchez C; Usenko CY; Herrera ND; Tambur AR
Clin Transplant; 2020 Aug; 34(8):e13906. PubMed ID: 32418254
[TBL] [Abstract][Full Text] [Related]
19. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
20. Positive virtual crossmatch with negative flow crossmatch results in two cases.
Jacob EK; De Goey SR; Gandhi MJ
Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
